Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
about
Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replicationHuman immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathwayTherapeutic targets for HIV-1 infection in the host proteome.Involvement of a small GTP binding protein in HIV-1 release.Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.Role of RNA helicases in HIV-1 replicationNUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoterProspects for treatment of latent HIV.Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.Naturally occurring compounds elicit HIV-1 replication in chronically infected promonocytic cells.Combinatorial latency reactivation for HIV-1 subtypes and variantsLyn regulates inflammatory responses in Klebsiella pneumoniae infection via the p38/NF-κB pathway.Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate.Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1Cell line-dependent variability in HIV activation employing DNMT inhibitorsInhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.Bridging HIV-1 cellular latency and clinical long-term non-progressor: an interactomic viewHexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activationGenome-wide search for the genes accountable for the induced resistance to HIV-1 infection in activated CD4+ T cells: apparent transcriptional signatures, co-expression networks and possible cellular processesMeasuring glutathione redox potential of HIV-1-infected macrophages.High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor.Apoptosis-induced activation of HIV-1 in latently infected cell linesThe ubiquitin-proteasome system in HIV replication: potential targets for antiretroviral therapy.Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switchTranscriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.Experimental approaches to the study of HIV-1 latency.Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins.High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.Identification of glycoproteins associated with HIV latently infected cells using quantitative glycoproteomics.HIV type-1 latency: targeted induction of proviral reservoirs.From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication.Rho'ing in and out of cells: viral interactions with Rho GTPase signalingResveratrol, sirtuins, and viruses.HIV-1 induced nuclear factor I-B (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region.HIV-1 infection suppresses expression of host cell cycle-associated gene PDS5A.Dual-color HIV reporters trace a population of latently infected cells and enable their purification.Inhibition of HIV-1 replication by small interfering RNAs directed against glioma pathogenesis related protein (GliPR) expressionEstablishment and maintenance of HIV latency: model systems and opportunities for intervention.Reactivation from latency displays HIV particle budding at plasma membrane, accompanying CD44 upregulation and recruitment.
P2860
Q21245214-29538CAA-C0C8-49A9-846C-141DB469AC12Q24530134-2282F2A7-0529-4237-BA99-3908B1F61559Q24795470-72804E3B-CB83-40E0-AE5E-FB290C9C14E6Q24815862-4F1174F7-251A-4BD5-903C-F3CEC772EE3AQ24815984-E34DC09B-949A-469B-AF7B-5F2DF0CDC8FDQ27477537-8F3FFB48-F7C7-43EC-B350-0EE958639E51Q28115345-CA37D660-44D3-4BC4-8C88-4FB76473FEBAQ30424413-681527EA-14CC-4DC6-BAF8-69DC8B92BF20Q33236503-E8A0103E-2873-4ED8-8195-BF8E4960BC3EQ33589167-5E066852-B6B2-40DE-BA02-310A0E479F5AQ33678299-56E0DBFB-458E-4377-ABFB-7E73836246E4Q33877492-1BD711BF-3735-4262-AEB7-CF8198916C79Q33922067-CBED67E2-12AB-4DB3-B751-BAF505A70A3AQ34186017-993836C1-1929-4F76-B5D7-FAF69C6FB7A4Q34200840-81BD5BD5-FA1E-48FD-8D8D-3C1EF985FE4FQ34243934-06802F25-37AE-46DD-AD08-607F56BF1FBEQ34352092-9FEB0B85-055E-42DC-85C0-3C04848BF566Q34602260-8DB60C85-4F91-4BDB-BF79-5741AAE9C8DFQ34647406-0A40FEE8-E11A-404B-810B-A4D400AD6F04Q34699192-8982A7BC-1520-40D4-A5E1-58D3C18A58FCQ34958392-9A814DD3-FF9A-4E2D-A41F-39C787770CACQ35065109-12C1E0E0-752C-4262-81DC-1749B9E8A48BQ35747595-8B7DB1FF-4F9B-4A70-AE6F-572C56E504CBQ36066214-4A5BA309-54F5-4709-831D-57BBD4D9C247Q36125264-1E432C9C-5F2E-4384-B481-2E67798E8FABQ36206925-841FFFEC-C61B-4108-8AAF-E06056A71AA4Q36708954-1C72123F-B32D-4E9E-98DE-86E2332A83B4Q36759698-FFDF0A72-D1DA-4CFD-B6F1-9E48CF3D087FQ37123276-E3C5974D-52F0-49DB-BD77-1C25173C1E8DQ37383798-C753E75B-DDED-4910-8B18-8CE05F7C6599Q37502488-32B7F6DA-3F87-482E-B35C-F8FFD889F73CQ38047419-A178EFD7-77EA-4FF7-BC96-4CADCBD487BDQ38201237-602224AF-EE12-4128-9E6D-E41F1E2AE6BDQ38610855-A6598C3E-FB69-48B3-9F10-9FE3F74F9CB4Q38911541-28E678B0-26BF-46B1-BC7F-3963BF5DE5B8Q39484912-987083EB-97DE-4807-99B7-F874C7D17D5BQ39544604-56709AC1-7D55-4785-B957-3D7F9BCC2AA4Q39720512-03E11757-182E-4271-AAFE-FAAC932E2C12Q39783316-3DBE1DB4-EA69-4542-9E4E-5D0E463F2300Q39826186-119403E1-1AE4-451E-B227-D58A6302EF1C
P2860
Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Host cell gene expression duri ...... ly expressed in viral latency.
@en
Host cell gene expression duri ...... ly expressed in viral latency.
@nl
type
label
Host cell gene expression duri ...... ly expressed in viral latency.
@en
Host cell gene expression duri ...... ly expressed in viral latency.
@nl
prefLabel
Host cell gene expression duri ...... ly expressed in viral latency.
@en
Host cell gene expression duri ...... ly expressed in viral latency.
@nl
P2860
P1433
P1476
Host cell gene expression duri ...... ly expressed in viral latency.
@en
P2093
Vyjayanthi Krishnan
P2860
P304
P356
10.1128/JVI.78.17.9458-9473.2004
P407
P577
2004-09-01T00:00:00Z